Core Insights - Pluri Inc. has launched a wholly-owned subsidiary, Cellav Health and Aesthetics Ltd., focusing on regenerative solutions using its proprietary 3D cell expansion platform [1][6] - Cellav has secured a commercial collaboration with Miss Universe Skincare to co-develop a new line of advanced, cell-based skincare products [1][2] - The first product from this collaboration is expected to launch in the first half of 2026, leveraging Miss Universe Skincare's global distribution platform [2][6] Company Overview - Cellav aims to transform cutting-edge cell science into impactful solutions for health and aesthetics, bridging science with real-world results [5][7] - The subsidiary will operate in three core areas: developing premium cell-derived ingredients, offering professional-use and consumer-ready products, and providing a flexible technology platform for partners [7] - Cellav's offerings are backed by over two decades of Pluri's expertise in pharmaceutical-grade development [7] Market Potential - The beauty market, where Cellav is expanding, is projected to reach $194.05 billion by 2032, indicating significant growth opportunities [6] - The collaboration with Miss Universe Skincare is seen as a strategic move to tap into high-growth, revenue-generating markets [2][4] Leadership and Vision - Cellav is led by CEO Katty Dowery, who has extensive experience in cell-based technologies and regenerative medicine [3][4] - The company emphasizes scientific integrity and high-quality standards, aiming to make regenerative science accessible and impactful in the beauty industry [4][5]